Purpose: This study was designed to illustrate the effects of C-reactive protein (CRP) and interleukin polymorphisms on serum CRP levels.
tive of one-year survival. 1) An association was also found between increased CRP levels and decreased heart rate variability.
2)
The human CRP gene, located at chromosome band 1q23, consists of two exons separated by a single intron containing a dinucleotide tandem repeat (GT)n.
3) Production of CRP is regulated by interleukin-1β , IL-1 receptor antagonist (IL-1-RA), and IL-6. Genetic variation at the CRP and in the components governing the inflammatory response has been shown to be associated with serum CRP levels.
Prior studies showed that 1059G > C located within exon 2 of the CRP gene was associated with lower baseline CRP. 4) The relationship persisted after adjustment for nongenetic confounders (eg, age, sex, and body mass index) and was present in subjects with and without prevalent coronary disease in a white population.
5) The polymorphic GT-repeat in the intron of the CRP gene contributes to variation in baseline CRP. Carriers of two GT (16) alleles, two GT (21) alleles, or GT (21) alleles had two-fold lower CRP levels both in normal individuals and in patients with inflammatory diseases. 6) Other possible associations with CRP levels included 1444C > T minor allele and 1846G > A in 3' untranslated region. 7) It was shown that -717A > G and the intervening sequence +29A > T were not associated with baseline CRP. 8, 9) The gene of the proinflammatory cytokine interleukin 1β (IL-1β) is a member of the IL1 gene family clustered on chromosome 2.
10) The association of IL-1β + 3954 C > T polymorphism on exon 5 has been observed in patients with CHD with two-fold higher median CRP levels with TT genotype as compared to CC genotype. 11) It was also shown that the dominant effect of the T allele was associated with higher CRP levels in heterozygous carriers compared with homozygotes for the C allele in patients with CHD. 12) A C > T polymorphism in the promoter region of IL-1β gene at position -511 influences protein production, with the highest level in T allele carriers. 13) Male carriers of -511T/T and -31C/C genotype had a higher body mass index (BMI) and lean body mass in patients with end-stage renal disease. However, the association with CRP level was not documented. 14) Intron 2 of the IL-RA gene contains identical tandem repeats (VNTR) of an 86-bp length of DNA. Alleles were coded according to the number of repeats (IL-RA VNTR*1: four repeats, IL-RA VNTR*2: two repeats; IL-RA VNTR*3: five repeats). 15) It has been postulated that IL-RA VNTR*2 might be associated with lower inflammatory activity, 16) but contradictory evidence exists.
17)
The aim of this study was to illustrate the polymorphic genotypes in CHD patients in the Taiwanese population, and to use a classification tree to identify the effects of polymorphisms in the genes coding for CRP, IL-1β, and IL-1-RA, and their interactions on serum CRP levels. 
METHODS
The study included patients who were admitted to National Taiwan University Hospital (NTUH) for coronary angiography during the period from March 2002 to August 2003. All patients were preliminarily diagnosed as CHD. A positive noninvasive test result, either treadmill study or thallium-201 scan, was preferred but not required. Subjects presenting with a high pretest probability of CHD were allowed to undergo coronary angiographic examination without noninvasive evaluation. Patients receiving examinations for valvular heart diseases, congenital heart diseases, and posttransplant evaluation were excluded. The study was approved by the institutional review board of NTUH.
Precatheterization evaluation included a basic physical examination (body weight and height), clarification of past history (including the presence of hypertension, diabetes, dyslipidemia, and smoking), and blood tests (fasting glucose, total cholesterol, high-density and low-density lipoprotein cholesterol, and triglycerides) performed on the morning of the procedure. Fasting plasma glucose was measured using the hexokinase-glucose dehydrogenase method with an Olympus AU-5000. Serum total cholesterol (CHO), high-density-lipoprotein The laboratory criteria defined a CRP level higher than 0.8 mg/L as elevated so as to achieve higher sensitivity for detecting an inflammatory status. The coronary angiographic examination categorized patients into 3 groups: 1) significant CHD requiring intervention therapy (at least one-vessel with stenosis greater than 70%), 2) significant coronary stenosis (at least one vessel greater than 50%) but an intervention was not performed, and 3) insignificant lesions or patent coronary arteries. Patients in the first two groups were included for SNP analysis.
The peripheral blood mononuclear cells were analyzed to determine SNPs for CRP + 1059 G > C (rs# 1800947), variable numbers of dinucleotide repeats in the CRP gene intron (rs# 3138528), IL-1β + 3954, IL-1β-511, IL-1β-31, and the VNTR of the IL-1RA. Genotyping of the polymorphisms was performed by a polymerase chain reaction based method, as previously reported and summarized in Table I . 12, [18] [19] [20] A recursive partitioning classification tree was developed, which selected each candidate variable, one at a time, and evaluated each observed value of that variable to determine the increments that maximized the selected criteria across all genetic and nongenetic factors.
21) The application, described in detail and illustrated by White and Kiernan, uses entropy-based criteria to select the split. A root node contains all of the eligible cases, and children nodes are created according to node splitting criteria. 21, 22) The information gain is maximized after each split; as leaf nodes grow level by level, a tree structure is developed.
23) The algorithm took into account all of the six polymorphisms (CRP + 1059, CRP (GT) dinucleotide tandem repeat, IL-1β + 3954, IL-1β-511, IL-1β-31, and IL-1 RA VNTR), and potential nongenetic confounding factors (age, sex, BMI, the presence of dyslipidemia, hypertension, and diabetes mellitus) as categorical predictors. Whether the serum CRP level was elevated (> 0.8 mg/L) was used as the class variable (outcome). The application stopped splitting a node when 1) a minimal size of 5 records, 2) 99% purity, or 3) a depth of 6 was reached. If the data for any one of the above-mentioned polymorphisms and demography were not available, the case was excluded from analysis. All of the data were ensured to be missing at random, ie, not simultaneously related to the measurements of CRP and genotype. Specific genotypes with a case number less than 3, which disabled the classification tree from splitting, were excluded from the analysis on a case- A classification tree decision program in Excel developed by Ross Quinlan (CTree 4.5) was downloaded from the Internet. 24) Statistical analysis was performed with SPSS 10.0 environment (SPSS Inc. Chicago, IL). The distribution of demographic data and laboratory results are presented as the mean ± standard deviation. Proportions were compared using the χ 2 test. Hardy-Weinberg equilibrium of the target SNPs was also reported in the χ 2 probability. Continuous variables were compared between independent groups using the t-test. CRP levels were transformed to an approximate normal distribution by log transformation before statistical analysis. The cases attributed to each node were selected and a logistic regression model was applied based on the conditional probability. The odds ratio (OR), 95% confidence intervals (95% CI), and P values are reported for the split beneath the node.
RESULTS
A total of 555 subjects (373 males and 182 females) underwent a coronary angiographic examination in the period from March 15, 2002 to August 19, 2003 (393 with significant CHD requiring intervention therapy, 27 with significant coronary stenosis without an intervention, and 135 excluded from SNP analysis because of insignificant lesions or patent coronary arteries). The demographic hsCRP indicates high-sensitivity C-reactive protein; N, case number; T-CHO, total cholesterol; TG, triglyceride; and SD, standard deviation. Age, T-CHO, and TG are reported as the mean ± SD. data of the 420 patients with angiographically proven CHD are shown in Table II . The mean age for the 301 men and 119 women was 63 ± 12 and 68 ± 10. The women recruited in this study were significantly older than the men, and the proportion of hypertension was also higher. The prevalence of diabetes mellitus was not statistically higher in the females.
Because the distribution of CRP was skewed to a higher concentration, the logarithm of CRP levels (mg/L) was reported (0.35 ± 0.70 for men and 0.53 ± 0.79 for women). Student's t-test was thus performed and women had a borderline higher concentration (P = 0.053). The 25 th percentile, median, and 75 th percentile The root node contained all of the 390 subjects. Splitting began from the root node and expanded to the leaf nodes. Hypertension was selected as the first predictor as it maximized the information gain. The descriptions and statistical significance of each node are shown in Tables IV and V. More leaves from splitting at deeper levels were pruned due to statistical insignificance.
The distribution of CRP-related SNP is presented in Table III . In addition to the most frequent CRP + 1059 genotype (GG), the heterozygote (GC) was seen in 16.4% and the homozygote (CC) was seen in 1.0% of the CHD patients. In terms of CRP dinucleotide tandem repeat polymorphism, most patients carried two GT (16) The presence of hypertension was the most important factor that resulted in the maximal information gain in the classification tree (Figure) . A total of 260 CHD patients (66.6%) had hypertension. Among the hypertensives, 76% had elevated CRP levels, in contrast to 65% in the nonhypertensives (Table IV) presence of hypertension resulted in an OR of 1.755 (P = 0.015, 95% CI: 1.118-2.755) for elevated CRP (Table V) .
In the hypertensive patients, CRP + 1059 (G/C) was associated with a lower CRP level. The OR for an elevated CRP level was 0.318 (P = 0.001, 95% CI: 0.162~0.623) compared to those with CRP + 1059 (G/G). In the hypertensive patients with CRP 1059 G/C, additional interaction with IL-1β-511 (C/T) and IL-1β-511 (T/T) was associated with a lower risk of elevated CRP (OR: 0.222, P = 0.088 and OR: 0.148, P = 0.060) compared with IL-1β-511 (C/C); however, the association had only borderline significance. In the hypertensive patients with CRP 1059 (G/G), additional interaction with IL-1β + 3954 (C/T) was associated with a lower risk of elevated CRP compared to with IL-1β + 3954 (C/C) with a borderline significance (OR: 0.241, P = 0.088) ( Table V) .
In the 130 nonhypertensive CHD patients, the best predictor that might provide maximal information gain in this group was equal numbers of tandem repeats in IL-1 RA. Compared to the patients with unequal VNTR in the two alleles, a nonsignificant risk reduction in elevated CRP was found (OR 0.205, P = 0.141) ( Table V) .
Further expansion of the classification tree failed to demonstrate any significant predictors of elevated CRP. Important factors, such as sex, the presence of smoking, diabetes mellitus, BMI, and dyslipidemia, did not show additional predictive capacity once the effect of hypertension was stratified and controlled.
DISCUSSION
Multiple loci on CRP and interleukin genes might have affected the production and serum levels of CRP. As well, nongenetic factors that were associated with CRP levels might interfere with interpretation of the genetic effect. Most of the previous studies used univariate analysis and multiple logistic regression methods to evaluate the effects of SNPs on CRP levels. Some studies have compared the difference between the use of the logistic regression model and the recursive partitioning classification tree. 21) From the point of view of "entropy" or "maximal likelihood", both methods are exactly the same. However, a recursive partitioning classification tree is advantageous in that it is easy to use and understand in a tree diagram rather than from an equation. 25) It is also useful for identifying interactions and subgroups in an automatic fashion, 26) which cannot be easily performed with a logistic regression model. Therefore, such a heuristic decision analysis tool should be used to illustrate the effects and interactions of multiple genetic and nongenetic determinants.
In our series, hypertension was the most important factor that could increase the frequency of elevated CRP in patients with CHD. Women enrolled in this study were older than the male companions by 5 years and more frequently presented with hypertension and diabetes. We performed a stratified analysis and found that in both the hypertensive and nonhypertensive groups, CRP levels were no longer associated with age or with the presence of diabetes. Therefore, the most important classifying factor in our series might have signified the cluster of risk factors such as hypertension, diabetes, and older age among the female patients.
Many studies have reported an association between elevated CRP levels and higher blood pressure. 27, 28) However, some evidence showed that the association was attributable to confounding factors rather than causality. 29) In addition, most recent reports demonstrate that BMI has the largest effect on the correlation with serum CRP levels. Kathiresan, et al demonstrated that 12 clinical covariates explained 26% of the variability in CRP levels, with BMI alone explaining 15% of the variance. 30) In a Dutch study aimed at investigating the relationship between CRP and components in the metabolic syndrome, the association between CRP and BP was weak and not statistically significant after careful stratification by weight status. 31) In our series, the patients with hypertension had a higher BMI compared to those without (25.4 ± 4.45 versus 24.2 ± 3.2, P = 0.009). Therefore, the presence of hypertension as the most important predictor might imply collinearity with the effects of aging, diabetes, and obesity. In the patients with significant CAD, the interaction between various cardiovascular risk factors is much more prominent than that of healthy subjects. Therefore, the process classifying the patients with CAD into hypertensives and nonhypertensives might have also clustered them into one multiple-risk group and another less-risky group.
In a Finnish study of healthy male blood donors, CRP + 1059GG homozygotes had low CRP concentrations only if they were allele-T carriers of IL-1β + 3954. The coexistence of CRP + 1059 GG and IL-1β + 3954 CC was associated with a 3-fold risk of a higher baseline CRP value (OR: 2.84). 32) Compared to the hypertensive patients carrying both CRP + 1059 GG and IL-1β + 3954 CT, a sim-Vol 48 No 4 ilar trend was found in our series.
Another potential predictor for lower CRP levels was IL-1β-511, but our result was inconclusive and only restricted to CRP + 1059 GC hypertensive patients. Although previous evidence by diGiovine gave contradictory results, 13) it is likely that the interaction between CRP + 1059 and IL-1β-511 polymorphisms provided specific genetic meaning. Further research should target more patients with concomitant consideration of both polymorphisms.
According to the search results from the Entrez SNP database of the National Center of Biotechnology Information, the allele frequency (C and G) for CRP + 1059 (rs# 1800947) is 0.090 and 0.910 for the Chinese population and 0.030 and 0.970 for the Japanese population. 33) Both are similar to our results (0.100 and 0.900) in Taiwanese people. The global genotype frequency for IL-1β + 3954 C/C and C/T is 0.993 and 0.007, respectively. 33) Our results in Taiwanese were 0.969 and 0.031. The allele and phenotype frequencies of CRP and IL-1β SNPs we identified are comparable with previously published results in other populations. Limitations: One limitation of our study was that we did not use serum CRP levels as the outcome measurements. Instead, we arbitrarily divided people into categories of elevated or normal CRP levels, according to a private laboratory reference. One reason was that the class (or outcome) variable in the classification tree should be categorical. On the other hand, since the distribution of serum CRP levels was widely distributed and highly skewed, CRP levels should be logarithmically transformed if conventional regression models (with adjustment) were to be applied. The logCRP in the hypertensive CAD patients carrying 1059GC was lower than in those with 1059 (G) (0.18 ± 0.70 versus 0.45 ± 0.66, P = 0.014). The fact that a similar trend was still preserved in the conventional approach supported the statement that a pruned classification tree that could automatically find the best predictors and adjust confounders has provided information about genetic determinants and their interactions.
Also, we did not differentiate essential hypertension from secondary hypertension. Therefore, we were unable to find any association between SNP variation and specific etiology of secondary hypertension. In addition, we did not include any information about antihypertensive agents, and thus the effects of CRP polymorphisms on treatment response to angiotensin converting enzyme inhibitors or angiotensin receptor blockers cannot be inferred. Dyslipidemia was defined as 1) TG ≥ 150 mg/dL, or 2) HDL ≤ 40 mg/dL in men or HDL ≤ 50 mg/ dL in women. The presence of dyslipidemia was not a significant classifier in our series. However, the association between CRP and individual components (HDL, LDL, and TG) might be different from that between CRP and dyslipidemia as a whole. Further studies will be needed to clarify this issue.
